Driving Productivity Across The Antibody Manufacturing Workflow

Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.

De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing

Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.

Autonomous Impinging Jet Mixing For LNP Process Development

Discover how impinging jet mixing combined with automation and data-driven optimization offers a more systematic path to identifying process parameters for scalable, reproducible LNP manufacturing.

How To Achieve Stable, High-Output Stickpack Production

Explore practical ways to improve stickpack production through accurate dosing, reliable sealing, automated quality control, and efficient material handling while reducing complexity.

Beyond Breakdowns: Building A Culture Of Proactive Maintenance

Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.

Building Robust Potency Assays

Robust potency assays depend on reliable biological readouts. Learn how quantitative protein expression analysis can provide sensitive, reproducible measurements of cellular responses.

How To Overcome Early Development Challenges Before They Impact Your Program

Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.

How Sponsors Should Evaluate Manufacturing Resilience

Learn how continuity planning, technology transfer capabilities, global network flexibility, and digital visibility contribute to resilient supply chains and help protect programs from disruption.

Enabling The Full Potential Of Process Chromatography

Real-time analytics can provide greater visibility into chromatography performance during scale-up, helping teams monitor purification, maintain critical process parameters and quality attributes.

A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings

Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.

AI-Readiness In A Regulated World: A Practical Playbook For Life Sciences

Uncover how life science teams build defensible governance, maintain human oversight, and manage regulatory risks when adopting advanced digital tools.

How To Define, Monitor, And Hit Critical Endpoints

Improve UF/DF repeatability by defining clear concentration and diafiltration endpoints, matching them with appropriate measurements, and applying real-time in-line analytics to reduce variability.

Characterizing Process Performance And Robustness In An End-To-End Cryopreserved Autologous CAR-T/TCR Workflow

A systematic evaluation of an end-to-end cryopreserved CAR-T workflow examines how critical process parameters and unit operation interdependencies affect manufacturing consistency and robustness.

Driving Measurable Productivity Gains In CHO Cell Culture

Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.

Take The Turbulence Out Of Your Transfections

Run-to-run AAV titer variability can jeopardize production. Controlling incubation timing, DNA input, and media conditions improves yield and batch consistency.

The Future Of Cell Culture Media Development

Predictive modeling and AI are helping reshape cell culture media. Learn how these approaches can focus experimental efforts, accelerate learning, and support more efficient development decisions.

From Data To Decisions: AI And Multi-Omics For Cell Culture Development

See how combining multi-omics data, AI-enabled analytics, and expertise can reveal the biological drivers of process performance, helping biologics developers identify optimization opportunities.

When Unexpected Particles Threaten Your Biologic

Particle contamination risks biologic safety. Advanced tools like Raman and SEM-EDS identify root causes fast to support robust, regulator-ready strategies that protect product quality.

Built For Growth: Engineering Flexible And Scalable Bioprocessing Strategies

Standardizing bioprocess platforms and automation logic simplifies cross-site tech transfer and mitigates workforce constraints during program scale-up.

How Modular Workflows Are Redefining CAR T Manufacturing

Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.

Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid

Learn how rational plasmid engineering and promoter optimization can significantly improve AAV productivity while reducing plasmid burden, paving the way for more efficient and scalable viral vector manufacturing.

Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance

Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.

When High-Stakes ADC Decisions Can't Wait for More Material or Better Data

Learn how a material-sparing analytical workflow can generate reliable data, reduce dependence on calibration assays, and support faster, more confident candidate evaluation.

Modular VFlexible Aseptic Filling Lines

Modular suites with built-in contamination control streamline sterile manufacturing—supporting complex products, faster timelines, greater flexibility, less disruption, and scalable fill‑finish.

Reducing Particulate-Related Batch Risk In Bioprocessing

Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.

Residual DNA Testing Across Biotherapeutics

Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.

Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity

A bottom-up, data-driven media design approach shows how targeted nutrient optimization overcomes metabolic limits to boost culture performance and titer while maintaining product quality and process consistency.

Building Scalable Non-Viral Gene-Edited Cell Therapy Processes

Rahul Purohit, Ph.D., discusses the challenges and opportunities of scaling non-viral gene-edited cell therapies, with practical guidance for balancing performance, cell quality, and manufacturing readiness.

Automating cell therapy manufacturing without redesigning established workflow

Automating Cell Therapy Manufacturing Without Redesigning Workflows

Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.